Orgenesis Introductory Video | Having trouble viewing the video? Click here to view in YouTube.
Welcome to Orgenesis
Orgenesis is a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting a patient’s own liver cells into functional insulin producing cells, as a treatment for diabetes. Pancreatic islet cell transplantation is considered the only available technology. However, it is extremely limited and impractical due to shortages of donor tissue and unnaceptable rejection rates by the the patient's immune system.Orgenesis believes that converting the diabetic patients own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection.
If successful, this could mean the end of diabetes as we now know it.
News Alert Subscription
2013 Gateway Conference
Orgenesis CEO Sav DiPasquale Presents at 2013 Gateway Conference
Click here to access